Αποτελέσματα αναζήτησης - "адренокортикотропный гормон"

1

Academic Journal

Adrenal Dysfunction in Severe Community-Acquired Pneumonia Requiring VenoVenous Extracorporeal Membrane Oxygenation ; Надпочечниковая дисфункция при тяжелой внебольничной пневмонии, потребовавшей применения вено-венозной экстракорпоральной мембранной оксигенации

Συγγραφείς: N. E. Altshuler, N. M. Kruglyakov, G. I. Bagzhanov, A. A. Dokukin, K. K. Gubarev, M. B. Kutsyi, K. A. Popugaev, Н. Э. Альтшулер, Н. М. Кругляков, Г. И. Багжанов, А. А. Докукин, К. К. Губарев, М. Б. Куцый, К. А. Попугаев

Πηγή: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 13, № 1 (2024); 150-155 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 13, № 1 (2024); 150-155 ; 2541-8017 ; 2223-9022

Θεματικοί όροι: адренокортикотропный гормон, hydrocortisone, cortisol, extracorporeal membrane oxygenation, adrenal glands, adrenocorticotropic hormone, гидрокортизон, кортизол, экстракорпоральная мембранная оксигенация, надпочечники

Περιγραφή αρχείου: application/pdf

Relation: https://www.jnmp.ru/jour/article/view/1804/1451; https://www.jnmp.ru/jour/article/view/1804/1540; Krishnan S, Schmidt GA. Hemodynamic monitoring in the extracorporeal membrane oxygenation patient. Curr Opin Crit Care. 2019;25(3):285–291. PMID: 30865613 https://doi.org/10.1097/MCC.0000000000000602; Annane D, Pastores SM, Rochwerg B, Arlt W, Balk RA, Beishuizen A, et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM). Crit Care Med. 2017;45(12):2078–2088. PMID: 28940011 https://doi.org/10.1097/CCM.0000000000002737; Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–1247. PMID: 34599691 https://doi.org/10.1007/s00134-021-06506-y; Töpfer L, Menk M, Weber-Carstens S, Spies C, Wernecke KD, Uhrig A, et al. Influenza A (H1N1) vs non-H1N1 ARDS: analysis of clinical course. J Crit Care. 2014;29(3):340–346. PMID: 24508203 https://doi.org/10.1016/j.jcrc.2013.12.013; Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36(6):1937–1949. PMID: 18496365 https://doi.org/10.1097/ccm.0b013e31817603ba; Téblick A, Peeters B, Langouche L, den Berghe GV. Adrenal function and dysfunction in critically ill patients. Nat Rev Endocrinol. 2019;15(7):417– 427. PMID: 30850749 https://doi.org/10.1038/s41574-019-0185-7; Dhillo WS, Kong WM, Le Roux CW, Alaghband-Zadeh J, Jones J, Carter G, et al. Cortisol-binding globulin is important in the interpretation of dynamic tests of the hypothalamic-pituitary-adrenal axis. Eur J Endocrinol. 2002;146(2):231–235. PMID: 11834433 https://doi.org/10.1530/eje.0.1460231; Combes A, Peek GJ, Hajage D, Hardy P, Abrams D, Schmidt M, et al. ECMO for severe ARDS: systematic review and individual patient data meta-analysis. Intensive Care Med. 2020;46(11):2048–2057. PMID: 33021684 https://doi.org/10.1007/s00134-020-06248-3; Ho JT, Al-Musalhi H, Chapman MJ, Quach T, Thomas PD, Bagley CJ, et al. Septic shock and sepsis: a comparison of total and free plasma cortisol levels. J Clin Endocrinol Metab. 2006;91(1):105–114. PMID: 16263835 https://doi.org/10.1210/jc.2005-0265; Loisa P, Uusaro A, Ruokonen E. A single adrenocorticotropic hormone stimulation test does not reveal adrenal insufficiency in septic shock. Anesth Analg. 2005;101(6):1792–1798. PMID: 16301260 https://doi.org/10.1213/01.ane.0000184042.91452.48; Bouachour G, Roy PM, Guiraud MP. The repetitive short corticotropin stimulation test in patients with septic shock. Ann Intern Med. 1995;123(12):962–963. PMID: 7486498 https://doi.org/10.7326/00034819-123-12-199512150-00018; https://www.jnmp.ru/jour/article/view/1804

Διαθεσιμότητα: https://www.jnmp.ru/jour/article/view/1804
https://doi.org/10.23934/2223-9022-2024-13-1-150-155

View record from BASE

2

Academic Journal

Cortisol as a cerebral cortex neurons apoptosis regulator in acute phase of ischemic stroke (clinical and pathological study) ; Кортизол как фактор, определяющий регуляцию апоптоза нейронов коры головного мозга в остром периоде ишемического инсульта (клинико-патоморфологическое исследование)

Συγγραφείς: S. P. Sergeeva, A. A. Savin, P. F. Litvitsky, L. R. Gorbacheva, A. V. Lyundup, I. D. Breslavich, L. A. Savin, С. П. Сергеева, А. А. Савин, П. Ф. Литвицкий, Л. Р. Горбачева, А. В. Люндуп, И. Д. Бреславич, Л. А. Савин

Πηγή: Neurology, Neuropsychiatry, Psychosomatics; Vol 16, No 1 (2024); 49-56 ; Неврология, нейропсихиатрия, психосоматика; Vol 16, No 1 (2024); 49-56 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2024-1

Θεματικοί όροι: норадреналин, stroke, cortisol, adrenocorticotropic hormone, stress, adrenaline, norepinephrine, инсульт, кортизол, адренокортикотропный гормон, стресс, адреналин

Περιγραφή αρχείου: application/pdf

Relation: https://nnp.ima-press.net/nnp/article/view/2182/1628; https://nnp.ima-press.net/nnp/article/view/2182/1639; Ризаев ЖА, Хайдаров НК. Клиническое, эпидемиологическое и этиопатогенетическое исследование ишемического инсульта. Журнал неврологии и нейрохирургических исследований. 2020;1(1):11-5. doi:10.26739/2181-0982-2020-1-2; Lossi L. The concept of intrinsic versus extrinsic apoptosis. Biochem J. 2022 Feb 11;479(3):357-84. doi:10.1042/BCJ20210854; Mohtasham N, Mahmoudabadi RZ, Mohajertehran F. Extrinsic and intrinsic pathways of apoptosis and related molecules in ischemic stroke. Central Asian J Med Pharm Sci Innovat. 2021;1(4):194-204. doi:10.22034/CAJMPSI.2021.04.04; Almeida A, Sanchez-Moran I, Rodriguez C. Mitochondrial-nuclear p53 trafficking controls neuronal susceptibility in stroke. IUBMB Life. 2021 Mar;73(3):582-91. doi:10.1002/iub.2453. Epub 2021 Mar 2.; Сергеева СП, Савин АА, Шишкина ЛВ, Виноградов ЕВ. Головной мозг после ишемического инсульта: клинико-гистологическое исследование. Журнал неврологии и психиатрии им. C.C. Корсакова. 2017;117(3-2):66-70. doi:10.17116/jnevro20171173266-70; Ostapchenko VG, Snir J, Suchy M, et al. Detection of Active Caspase-3 in Mouse Models of Stroke and Alzheimer's Disease with a Novel Dual Positron Emission Tomography/Fluorescent Tracer [68Ga] Ga-TC3-OGDOTA. Contrast Media Mol Imaging. 2019;2019(6403274):1-17. doi:10.1155/2019/6403274; Devel L, Guedeney N, Bregant S, et al. Role of metalloproteases in the CD95 signaling pathways. Front Immunol. 2022 Dec 5;13:1074099. doi:10.3389/fimmu.2022.1074099; Lorente L, Martin MM, Perez-Cejas A, et al. Blood soluble Fas concentrations and ischemic stroke patient mortality. Expert Rev Mol Diagn. 2022 Dec;22(12):1117-21. doi:10.1080/14737159.2022.2165913. Epub 2023 Jan 9.; Ichim G, Tait SW. A fate worse than death: apoptosis as an oncogenic process. Nat Rev Cancer. 2016 Aug;16(8):539-48. doi:10.1038/nrc.2016.58. Epub 2016 Jul 1.; Falkenburger B, Reich A. The two sides of Faim2: modulation of cell death and regeneration. J Neurol Neuromed. 2017;2(1):14-8.; Mao R, Zong N, Hu Y, et al. Neuronal Death Mechanisms and Therapeutic Strategy in Ischemic Stroke. Neurosci Bull. 2022 Oct;38(10):1229-47. doi:10.1007/s12264-022-00859-0. Epub 2022 May 5.; Сергеева СП, Савин АА, Литвицкий ПФ и др. Закономерности активации стресс-реализующей системы и ее влияние на течение и исход острого периода ишемического инсульта. Вестник новых медицинских технологий. 2022;16(2):6-12.; Xu B, Lang LM, Li SZ, et al. Cortisol Excess-Mediated Mitochondrial Damage Induced Hippocampal Neuronal Apoptosis in Mice Following Cold Exposure. Cells. 2019 Jun 18;8(6):612. doi:10.3390/cells8060612; Lucassen PJ, Heine VM, Muller MB, et al. Stress, depression and hippocampal apoptosis. CNS Neurol Disord Drug Targets. 2006 Oct;5(5):531-46. doi:10.2174/187152706778559273; Парфенов ВА. Постинсультная депрессия: распространенность, патогенез, диагностика и лечение. Неврология, нейропсихиатрия, психосоматика. 2012;4(4):84-8. doi:10.14412/2074-2711-2012-428; Котов СВ, Исакова ЕВ, Егорова ЮВ. Постинсультная депрессия и возможности антидепрессантов в повышении эффективности нейрореабилитации. Неврология, нейропсихиатрия, психосоматика. 2020;12(6):110-6. doi:10.14412/2074-2711-2020-6-110-116; Ли С, Розыбакиева З, Асимов М, Багиярова Ф. Психотерапия на базе копинг-стратегии. Сравнение современных методов. Валеология: Здоровье, Болезнь, Выздоровление. 2022;(4):141-6.; De Kloet ER, Joёls M. The cortisol switch between vulnerability and resilience. Mol Psychiatry. 2023 Jan 4. doi:10.1038/s41380-022-01934-8. Epub ahead of print.; Perez-Tejada J, Garmendia L, Labaka A, et al. Active and Passive Coping Strategies: Comparing Psychological Distress, Cortisol, and Proinflammatory Cytokine Levels in Breast Cancer Survivors. Clin J Oncol Nurs. 2019 Dec 1;23(6):583-90. doi:10.1188/19.CJON.583-590; Hinwood M, Ilicic M, Gyawali P, et al. Psychological Stress Management and Stress Reduction Strategies for Stroke Survivors: A Scoping Review. Ann Behav Med. 2023 Feb 4;57(2):111-30. doi:10.1093/abm/kaac002

Διαθεσιμότητα: https://nnp.ima-press.net/nnp/article/view/2182
https://doi.org/10.14412/2074-2711-2024-1-49-56

View record from BASE

3

Report

Оценка значимости условий содержания и кормления молодняка крупного рогатого скота в развитии физиологического стресса

Θεματικοί όροι: адренокортикотропный гормон, cattle, adrenocorticotropic hormone, крупный рогатый скот, кортизол, cortisol

4

Academic Journal

ПЕРВИЧНАЯ НАДПОЧЕЧНИКОВАЯ НЕДОСТАТОЧНОСТЬ

Θεματικοί όροι: надпочечниковая недостаточность, жизнеугрожающее заболевание, стероидная карта, адренокортикотропный гормон, кортизол

5

Academic Journal

Adrenal Dysfunction Caused by a Critical Condition During Extracorporeal Membrane Oxygenation ; Надпочечниковая дисфункция, вызванная критическим состоянием. Экстракорпоральная мембранная оксигенация. Применение естественного гидрокортизона

Συγγραφείς: N. E. Altshuler, K. K. Gubarev, M. B. Kutsy, K. A. Popugayev, Н. Э. Альтшулер, К. К. Губарев, М. Б. Куцый, К. А. Попугаев

Πηγή: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 12, № 1 (2023); 66-77 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 12, № 1 (2023); 66-77 ; 2541-8017 ; 2223-9022

Θεματικοί όροι: вызванная критическим состоянием, надпочечниковая дисфункция, адренокортикотропный гормон, кортизол, септический шок, пневмония, экстракорпоральная мембранная оксигенация, ЭКМО

Περιγραφή αρχείου: application/pdf

Relation: https://www.jnmp.ru/jour/article/view/1571/1276; https://www.jnmp.ru/jour/article/view/1571/1297; Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36(6):1937–1949. PMID: 18496365 https://doi.org/10.1097/ccm.0b013e31817603ba; Annane D, Pastores SM, Rochwerg B, Arlt W, Balk RA, Beishuizen A, et al. Guidelines for the diagnosis and management of critical illnessrelated corticosteroid insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM). Crit Care Med. 2017;45(12):2078–2088. PMID: 28938253 https://doi.org/10.1097/CCM.0000000000002737; Евдокимова Е.А., Власенко А.В., Авдеева С.Н. Респираторная поддержка пациентов в критическом состоянии. Москва: ГЕОТАР-Медиа; 2021.; Extracorporeal Life Support Organization (ELSO) General Guidelines for all ECLS Cases. URL: https://www.elso.org/Portals/0/ELSO%20Gui delines%20General%20All%20ECLS%20Version%201_4.pdf [Accessed February 20, 2023].; Boonen E, Van den Berghe G. Endocrine responses to critical illness: novel insights and therapeutic implications. J Clin Endocrinol Metab. 2014;99(5):1569–1582. PMID: 24517153 https://doi.org/10.1210/ jc.2013-4115; Arlt W, Allolio B. Adrenal insufficiency. Lancet. 2003;361(9372):1881– 1893. PMID: 12788587 https://doi.org/10.1016/S0140-6736(03)13492-7; Lee MK, Vasikaran S, Doery JC, Wijeratne N, Prentice D. Cortisol: ACTH ratio to test for primary hypoadrenalism: a pilot study. Postgrad Med J. 2013;89:617–620. PMID: 23729816 https://doi.org/10.1136/ postgradmedj-2012-131723; Oelkers W, Diederich S, Bähr V. Diagnosis and therapy surveillance in Addison’s disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone. J Clin Endocrinol Metab. 1992;75:259–264. PMID: 1320051 https://doi. org/10.1210/jcem.75.1.1320051; Roux Le CW, Meeran K, Alaghband-Zadeh J. Is a 0900-h serum cortisol useful prior to a short synacthen test in outpatient assessment? Ann Clin Biochem. 2002;39(2):148–150. PMID: 11930947 https://doi.org/10 .1258/0004563021901919; Meduri GU, Yates CR. Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS. Ann N Y Acad Sci. 2004;1024:24–53. PMID: 15265772 https://doi.org/10.1196/annals.1321.004; Erturk E, Jaffe CA, Barkan AL. Evaluation of the integrity of the hypothalamicpituitary-adrenal axis by insulin hypoglycemia test. J Clin Endocrinol Metab. 1998;83:2350–2354. PMID: 9661607 https://doi. org/10.1210/jcem.83.7.4980; Rehan M, Raizman JE, Cavalier E, Don-Wauchope AC, Holmes DT. Laboratory challenges in primary aldosteronism screening and diagnosis. Clin Biochem. 2015;48:377–387. PMID: 25619896 https://doi. org/10.1016/j.clinbiochem.2015.01.003; Фадеев В.В., Мельниченко Г.А. Надпочечниковая недостаточность (клиника, диагностика, лечение): методические рекомендации для врачей. Москва: Медпрактика-М; 2003.; Jenkins D, Forsham PH, Laidlaw JC, Reddy WJ, Thorn GW. Use of ACTH in the diagnosis of adrenal cortical insufficiency. Am J Med. 1955;18:3– 14. PMID: 13218033 https://doi.org/10.1016/0002-9343(55)90200-X; Reimondo G, Bovio S, Allasino B, Terzolo M, Angeli A. Secondary hypoadrenalism. Pituitary. 2008;11:147–154. PMID: 18418713 https:// doi.org/10.1007/s11102-008-0108-4; Dhillo WS, Kong WM, Le Roux CW, Alaghband-Zadeh J, Jones J, Carter G, et al. Cortisol-binding globulin is important in the interpretation of dynamic tests of the hypothalamic-pituitary-adrenal axis. Eur J Endocrinol. 2002;146:231–235. PMID: 11834433 https://doi.org/10.1530/ eje.0.1460231; Combes A, Peek GJ, Hajage D, Hardy P, Abrams D, Schmidt M, et al. ECMO for severe ARDS: systematic review and individual patient data meta-analysis. Intensive Care Med. 2020;46(11):2048–2057. PMID: 33021684 https://doi.org/10.1007/s00134-020-06248-3; Ho JT, Al-Musalhi H, Chapman MJ, Quach T, Thomas PD, Bagley CJ, et al. Septic shock and sepsis: a comparison of total and free plasma cortisol levels. J Clin Endocrinol Metab. 2006;91:105–114. PMID: 16263835 https://doi.org/10.1210/jc.2005-0265; Loisa P, Uusaro A, Ruokonen E. A single adrenocorticotropic hormone stimulation test does not reveal adrenal insufficiency in septic shock. Anesth Analg. 2005;101:1792–1798. PMID: 16301260. https://doi. org/10.1213/01.ane.0000184042.91452.48; Bouachour G, Roy PM, Guiraud MP. The repetitive short corticotropin stimulation test in patients with septic shock. Ann Intern Med. 1995;123:962–963. PMID: 7486498 https://doi.org/10.7326/0003-4819- 123-12-199512150-00018; Téblick A, Peeters B, Langouche L, den Berghe GV. Adrenal function and dysfunction in critically ill patients. Nat Rev Endocrinol. 2019;15(7):417– 427. PMID: 30850749 https://doi.org/10.1038/s41574-019-0185-7; Berghe GV den, Zegher F de, Veldhuis JD, Wouters P, Gouwy S, Stockman W, et al. Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone secretagogues. Clin Endocrinol (Oxf). 1997;47:599–612. PMID: 9425400 https://doi.org/10.1046/j.1365-2265.1997.3371118.x; Peeters B, Langouche L, Van den Berghe G. Adrenocortical stress response during the course of critical illness. Compr Physiol. 2017;8(1):283–298. PMID: 29357129 https://doi.org/10.1002/cphy.c170022; Nickler M, Ottiger M, Steuer C, Kutz A, Christ-Crain M, Zimmerliet W, et al. Time-dependent association of glucocorticoids with adverse outcome in community-acquired pneumonia: a 6-year prospective cohort study. Critical Care. 2017;21:72. PMID: 28335807 https://doi. org/10.1186/s13054-017-1656-7; Schwingshackl A, Meduri GU. Rationale for prolonged glucocorticoid use in pediatric ARDS: what the adults can teach us. Front Pediatr. 2016;4:58. PMID: 27379217 https://doi.org/10.3389/fped.2016.00058; Меркулов В.М., Меркулова Т.И. Изоформы рецептора глюкокортикоидов, образующиеся в результате альтернативного сплайсинга и использования альтернативных стартов трансляции МРНК. Вавиловский журнал генетики и селекции. 2011;15(4):621–632.; Мельниченко Г.А., Трошина Е.А., Юкина М.Ю., Платонова Н.М., Бельцевич Д.Г. Клинические рекомендации Российской Ассоциации Эндокринологов (РАЭ) по диагностике и лечению первичной надпочечниковой недостаточности у взрослых пациентов (проект). URL: https://www.endocrincentr.ru/sites/default/files/specialists/science/ clinic-recomendations/consilium_2017.pdf [Дата обращения 20 февраля 2023 г.]; Государственный реестр лекарственных средств. URL: https:// minzdrav.gov.ru/opendata/7707778246-grls/visual [Дата обращения 20 февраля 2023г.]; Comparison of systemic glucocorticoid preparations – UpToDate. URL: https://www.uptodate.com/contents/image?imageKey=ENDO%2F6413 8 [Accessed February 20, 2023].; Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y, et al. Corticosteroids for treating sepsis. Cochrane Database Syst Rev. 2015;12:CD002243. PMID: 31808551 https://doi.org/10.1002/14651858. CD002243.pub4; Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med. 1998;26(4):645–650. PMID: 9559600 https://doi.org/10.1097/00003246-199804000-00010; Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med. 1999;27(4):723–732. PMID: 10321661 https://doi. org/10.1097/00003246-199904000-00025; Bone RG, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987;317(11):653–658. PMID: 3306374 https://doi.org/10.1056/NEJM198709103171101; Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis. 1988;138(1):62–68. PMID: 3202402 https://doi.org/10.1164/ajrccm/138.1.62; Chawla K, Kupfer Y, Goldman I, Tessler S. Hydrocortisone reverses refractory septic shock. Crit Care Med. 1999;27(1S):A33. https://doi. org/10.1097/00003246-199901001-00022; Annane D, Sebille V, Charpentier C, Bollaert PE, François B, Korach JM, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288(7):862–871. PMID: 12186604 https://doi.org/10.1001/ jama.288.7.862; Oppert M, Schindler R, Husung C, Offerman K, Graef KJ, Boenisch O, et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med. 2005;33:2457–2464. PMID: 16276166 https://doi.org/10.1097/01. ccm.0000186370.78639.23; Confalonieri M, Urbino R, Potena A, Piatella M, Parigi P, Giacomo P, et al. Hydrocortisone infusion for severe community acquired pneumonia: apreliminary randomized study. Am J Respir Crit Care Med. 2005;171:242– 248. PMID: 15557131 https://doi.org/10.1164/rccm.200406-808OC; Tandan SM, Guleria R, Gupta N. Low dose steroids and adrenocortical insufficiency in septic shock: a double blind randomised controlled trial from India. Am J Respir Crit Care Med. 2005;171:A43.; Rinaldi S, Adembri C, Grechi S, de Gaudio R. Low-dose hydrocortisone during severe sepsis: effects on microalbuminuria. Crit Care Med. 2006;34:2334–2339. PMID: 16850006 https://doi.org/10.1097/01. CCM.0000233872.04706.BB; Cicarelli DD, Vieira JE, Bensenor FEM. Early dexamethasone treatment for septic shock patients: a prospective randomized clinical trial. Sao Paulo Med J. 2007;125(4):237–241. PMID: 17992396 https://doi. org/10.1590/s1516-31802007000400009; Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998;280(2):159–165. PMID: 9669790 https://doi.org/10.1001/ jama.280.2.159; Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, et al. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Medicine. 1984;311(18):1137– 1143. PMID: 6384785 https://doi.org/10.1056/NEJM198411013111801; Hu B, Li JG, Liang H, Zhou Q, Yu Z, Li L, et al. The effect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009;21:529–531. PMID: 19751560 https://doi.org/10.3760/ CMA.J.ISSN.1003-0603.2009.09.006; Snijders D, Daniels JM., de Graaff CS, van der Werf TS, Boersma WG. Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med. 2010;181(9):975–982. PMID: 20133929 https://doi.org/10.1164/ rccm.200905-0808OC; Arabi YM, Aljumah A, Dabbagh O, Tamim HM, Rishu AH, Al-Abdulkareem A, et al. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. CMAJ. 2010;182:1971– 1977. PMID: 21059778 https://doi.org/10.1503/cmaj.090707; Yildiz O, Doganay M, Aygen B, Guven M, Keleutimur F, Tutuu A. Physiologic-dose steroid therapy in sepsis. Crit Care. 2002;6(3):251– 259. PMID: 12133187 https://doi.org/10.1186/cc1498; Yildiz O, Tanriverdi F, Simsek S, Aygen B, Kelestimur F. The effects of moderate-dose steroid therapy in sepsis: a placebo-controlled, randomized study. J Res Med Sci. 2011;16:1410–1421. PMID: 22973341; Meijvis SC, Hardeman H, Remmelts HH, Heijligenberg R, Rijkers GT, van Velzen-Blad H, et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, doubleblind, placebocontrolled trial. Lancet. 2011;377(9782):2023–2030. PMID: 21636122 https://doi.org/10.1016/S0140-6736(11)60607-7; Sabry NA, El-Din Omar E. Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacology and Pharmacy. 2011;2(2):73–81. https://doi.org/10.4236/pp.2011.22009; Liu L, Li J, Huang YZ, Liu SQ, Yang CS, Guo FM, et al. The effect of stress dose glucocorticoid on patients with acute respiratory distress syndrome combined with critical illness-related corticosteroid insufficiency. Zhonghua Nei Ke Za Zhi. 2012;51(8):599–603. PMID: 23158856; Rezk NA, Ibrahim AM. Effects of methyl prednisolone in early ARDS. Egypt J Chest Dis Tuberc. 2013;62(1):167–172. https://doi.org/10.1016/ J.EJCDT.2013.02.013; Gordon AC, Mason AJ, Perkins GD, Ashby D, Brett SJ. Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH). BMJ Open. 2014;4:e005866. PMID: 24993769 https://doi.org/10.1136/bmjopen-2014-005866; Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community- acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015;313(7):677–686. PMID: 25688779 https://doi.org/10.1001/jama.2015.88; Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med. 1987;317(11):659-665. PMID: 2888017 https://doi.org/10.1056/NEJM198709103171102; Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg. 1976;184(3):333–341. PMID: 786190 https://doi.org/10.1097/00000658- 197609000-00011; Sprung C, Annane D, Keh D, Moreno R, Singer M, Freivogel K, et al. Hydrocortisone therapy for patients with septic shock. N England Journal of Medicine. 2008;358(2):111–124. https://doi.org/10.1056/ NEJMoa071366; Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316(5):509–518. PMID: 27483065 https://doi. org/10.1001/jama.2016.10485; Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, et al. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med. 2018;378(9):809–818. PMID: 29490185 https://doi. org/10.1056/NEJMoa1705716; Regard S, Butler E, Granholm A, Moller MH, Cohen J, Finfer S, et al. Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2018;44(7):1003–1016. PMID: 29761216 https://doi.org/10.1007/ s00134-018-5197-6; Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–1247. PMID: 34599691 https://doi.org/10.1007/ s00134-021-06506-y; Siemieniuk RAC, Meade MO, Alonso-Coello P, Briel M, Evaniew N, Prasad M, et al. Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and metaanalysis. Ann Intern Med. 2015;163(7):519–528. PMID: 26258555 https://doi.org/10.7326/M15-0715; Mentzelopoulos SD, Malachias S, Chamos S, Konstantopoulos D, Ntaidou T, Papastylianou A, et al. Vasopressin, steroids, and epinephrine and neurologically favorable survival after in-hospital cardiac arrest. JAMA. 2013;310(3):270–279. PMID: 23860985 https://doi.org/10.1177/ 1751143714564514; Tsai MS, Huang CH, Chang WT, Chen WJ, Hsu CY, Hsieh CC, et al. The effect of hydrocortisone on the outcome of out-of-hospital cardiac arrest patients: a pilot study. Am J Emerg Med. 2007;25(3):318–325. PMID: 17349907 https://doi.org/10.1016/j.ajem.2006.12.007; Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43(3):304– 377. PMID: 2801605 https://doi.org/10.1007/s00134-017-4683-6; Rubartelli A, Lotze MT. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol. 2007;28(10):429–436. PMID: 17845865 https://doi.org/10.1016/ j.it.2007.08.004; Zindel J, Kubes P. DAMPs, PAMPs, and LAMPs in Immunity and Sterile Inflammation. Annu Rev Pathol. 2020;15:493–518. PMID: 31675482 https://doi.org/10.1146/annurev-pathmechdis-012419-032847; Кроненберг Г.М. Мелмед Ш., Полонски К.С., Ларсен П.Р. Эндокринология по Вильямсу. Нейроэндокринология. Москва: ГЭОТАР-Медиа; 2010.; Тучина О.П. Нейро-иммунные взаимодействия в холинергическом противовоспалительном пути. Гены и Клетки. 2020;15(1):23–28.; Akrout N, Sharshar T, Annane D. Mechanisms of brain signaling during sepsis. Curr Neuropharmacol. 2009;7(4):296–301. PMID: 20514209 https://doi.org/10.2174/157015909790031175; Millar JE, Fanning JP, McDonald CI, McAuley DF, Fraser JF, et al. The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit Care. 2016;20(1):387. PMID: 27890016 https://doi.org/10.1186/s13054-016-1570-4; Vanhorebeek I, Langouche L, Berghe den GV. Endocrine aspects of acute and prolonged critical illness. Nat Clin Pract Endocrinol Metab. 2006;2(1):20–31. PMID: 16932250 https://doi.org/10.1038/ ncpendmet0071; Deussing J, Chen А. The corticotropin-releasing factor family: physiology of the stress respons. Physiol Rev. 2018;98(4):2225–2286. PMID: 30109816 https://doi.org/10.1152/physrev.00042.2017; Crowder CM, Evers AS. Essential drugs in anesthetic practice: Mechanisms of anesthetic action. Anesthetic pharmacology basic principles and clinical practice. 2nd ed. Cambridge University Press; 2011:359-384. https://doi.org/10.1017/CBO9780511781933.025; Шмидт Р.В., Ланг Ф., Хекманн М. (ред.) Физиология человека с основами патофизиологии. Москва: Лаборатория знаний; 2021. Т. 2; https://www.jnmp.ru/jour/article/view/1571

Διαθεσιμότητα: https://www.jnmp.ru/jour/article/view/1571
https://doi.org/10.23934/2223-9022-2023-12-1-66-77

View record from BASE

6

Academic Journal

Изменения в системе гипофиз–надпочечники при применении экстракорпоральной мембранной оксигенации: проспективное исследование

Συγγραφείς: Н. Э. Альтшулер, М. Б. Куцый, Н. М. Кругляков, К. К. Губарев, Г. И. Багжанов, Константин Александрович Попугаев

Πηγή: Вестник интенсивной терапии, Iss 3 (2022)

Θεματικοί όροι: критическое состояние, гидрокортизон, кортизол, экстракорпоральная мембранная оксигенация, надпочечники, адренокортикотропный гормон, Medical emergencies. Critical care. Intensive care. First aid, RC86-88.9

Περιγραφή αρχείου: electronic resource

Relation: https://intensive-care.ru/index.php/acc/article/view/301; https://doaj.org/toc/1726-9806; https://doaj.org/toc/1818-474X

Σύνδεσμος πρόσβασης: https://doaj.org/article/6f084672a5b747c492f2d6a9e119093c

View record in DOAJ

7

Academic Journal

Гистологическая картина АКТГ-эктопического синдрома

Πηγή: Вопросы устойчивого развития общества.

Θεματικοί όροι: кортиколиберин, глюкокортикоиды, glucocorticoids, гипофиз, адренокортикотропный гормон, pituitary gland, adrenocorticotropic hormone, базофильные клетки, ACTH ectopic syndrome, corticoliberin, basophilic cells, АКТГ-эктопический синдром, 3. Good health

8

Report

Коррекция психонейрогормональных нарушений и качества жизни у больных истинной экземой с применением аргинил-a-аспартил-лизил-валил-тирозил-аргинина

Θεματικοί όροι: экзема, тревожность, arginyl-a-aspartyl-lysyl-valyl-tyrosyl-arginine, адренокортикотропный гормон, adrenocorticotropic hormone, аргинил-a-аспартил-лизил-валил-тирозил-аргинин, кортизол, качество жизни, eczema, cortisol, anxiety, quality of life

9

Academic Journal

Medullary Thyroid Cancer: Management Guidelines

Συγγραφείς: F M Abdulkhabirova, D G Bel'tsevich, V E Vanushko, I I Dedov, N S Kuznetsov, G A Mel'nichenko, N M Platonova, P O Rumyantsev, E A Troshina, A N Tyul'pakov, V V Fadeev, M A Kropotov, L N Lyubchenko, A M Mudunov, S O Podvyaznikov, V G Polyakov, I S Romanov, S Subramanian, S A Tyulyandin, V Zh Brzhezovskiy, A Yu Abrosimov, A A Il'in, P A Isaev, V S Medvedev, U V Rumyantseva, V O Ol'shanskiy, I V Reshetov, A N Makhson, V O Bondarenko, P S Vetshev, D V Zaletaev, Yu V Ivanov, L G Kozhanov, I V Soldatov, S S Kharnas, A S Barchuk, L M Bershteyn, I V Sleptsov, R A Chernikov, A N Bubnov, E N Grineva, G M Manikhas, A F Romanchishen, S V Korenev, I V Vikhlyanov, A D Gashchenko, V V Dvornichenko, A V Kiyaev, V A Privalov, S V Yaytsev, P V Svetitskiy, R Sh Khasanov, V A Tsvetaev, E L Choynzonov, S P Shevchenko

Πηγή: Эндокринная хирургия, Vol 7, Iss 2, Pp 4-16 (2013)

Θεματικοί όροι: адренокортикотропный гормон, дистанционная лучевая терапия, кортикотропинрилизинггормон, компьютерная томография, раковоэмбриональный антиген, магнитнорезонансная томография, медуллярный рак щитовидной железы, множественная эндокринная неоплазия, с-клеточная гиперплазия, первичный гиперпаратиреоз, паратиреоидный гормон, позитронно-эмиссионная томография, тонкоигольная аспирационная биопсия, ультразвуковое исследование, щитовидная железа, Surgery, RD1-811

Περιγραφή αρχείου: electronic resource

Relation: https://surg-endojournals.ru/serg/article/viewFile/6377/4223; https://doaj.org/toc/2306-3513; https://doaj.org/toc/2310-3965

Σύνδεσμος πρόσβασης: https://doaj.org/article/20b518f362ce4c0fbfdea11f9e4327ca

View record in DOAJ Full Text Finder

10

Academic Journal

Особенности клинической картины, диагностики и лечения болезни Иценко—Кушинга у детей

Συγγραφείς: Solntsava, A. V., Volkava, N. V.

Πηγή: Ukrainian Journal of Pediatric Endocrinology; № 1 (2018); 5-12
Украинский журнал детской эндокринологии; № 1 (2018); 5-12
Український журнал дитячої ендокринології; № 1 (2018); 5-12

Θεματικοί όροι: хвороба Іценка—Кушинга, діти, кортизол, адренокортикотропний гормон, індекс маси тіла, швидкість росту, болезнь Иценко—Кушинга, дети, адренокортикотропный гормон, индекс массы тела, скорость роста, Cushing's disease, children, cortisol, adrenocorticotropic hormone, body mass index, growth rate, 3. Good health

Περιγραφή αρχείου: application/pdf

Σύνδεσμος πρόσβασης: http://ujpe.com.ua/article/view/128824

View record at OpenAIRE

11

Academic Journal

Reproductive health of girls with congenital adrenal hyperplasia ; Репродуктивное здоровье девочек с врожденной гиперплазией коры надпочечников

Συγγραφείς: L. V. Adamyan, E. A. Bogdanova, E. V. Sibirskaya, T. M. Glybina, M. B. Garunova, Л. В. Адамян, Е. А. Богданова, Е. В. Сибирская, Т. М. Глыбина, М. Б. Гарунова

Πηγή: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 59, № 2 (2014); 43-47 ; Российский вестник перинатологии и педиатрии; Том 59, № 2 (2014); 43-47 ; 2500-2228 ; 1027-4065 ; undefined

Θεματικοί όροι: адренокортикотропный гормон, congenital adrenal hyperplasia, reproductive health, 11'-hydroxyprogesterone, adrenocorticotropic hormone, врожденная гиперплазия коры надпочечников, репродуктивное здоровье, 17-гидроксипрогестерон

Περιγραφή αρχείου: application/pdf

Relation: https://www.ped-perinatology.ru/jour/article/view/203/243; BongiovanniA.M., RootA.W. The adrenogenital syndrome. N Engl J Med 1963; 268: 1283-1399.; Gallais A. Le syndrome genitosurrenal, etude anatomo-clinique. Paris 1912; 224.; Верещинский А. О. Надпочечно-половой синдром с точки зрения хирургической патологии и терапии. Вестн хир 1923; 4: 3: 207—219. (Vereshchynsky A.O. Adrenal-sexual syndrome in terms of surgical pathology and therapy. Vestn khir 1923; 4: 3: 207-219.); Therrell B. Newborn screening for congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 2001; 1:15—30.; Pang S., Murphey W., Levine L.S. et al. A pilot newborn screening for congenital adrenal hyperplasia in Alaska. J Clin Endocrinol Metab 1982; 3: 413-420.; Pang S., Wallace M. Hofman L. et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988; 6: 866—874.; Speiser P., Dupont В., Rubinstein P. et al. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985; 4: 650—667.; Fitness J., Dixit N., Webster D. et al. Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1999; 3: 960—966.; Cam J., Moshang T. Jr., Bongiovanni A.M. et al. Elevated 17-hydroxyprogesterone and testosterone in a newborn with; beta-hydroxysteroid dehydrogenase deficiency. N Engl J Med 1985; 10: 618-621.; Speiser P., Dupont J., Zhu D. et al. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 1992; 2: 584—595.; Wtchel S., Lee P. /dentification of heterozygotic carriers of 21-hydroxylase deficiency: sensitivity of ACTH stimulation tests. Am J Med Genet 1982; 4: 337—342.; Clayton P., Miller W., Oberfield S.E. et al. Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Horm Res 2002; 4: 188—195.; White P., Speiser P. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000; 3: 245—291.; Pang S., Spence D.A., New M.I. Newborn screening for congenital adrenal hyperplasia with special reference to screening in Alaska. AnnNYAcad Sci 1985; 458: 90—102.; Pang S.Y., Wallace M.A., Hofman L. et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988; 81:6:866—874.; Карева М.А., Орлова Е.М. Адреногенитальный синдром: прошлое, настоящее и будущее. Пробл эндокринол 2011; 1: 66—70. (Kareva M.A., Orlova E.M. Adrenogenital syndrome: past, present and future. Probljendokrinol 2011; 1: 66-70.); Forest M., Morel Y, David M. et al. Prenatal treatment of congenital adrenal hyperplasia. Trends Endocrinol Metab 1998; 7: 284-289.; New M., Carlson A., Obeid J. et al. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab 2001; 12: 5651-5657.; Morel Y, Miller L. Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv Hum Genet 1991; 20: 1—68.; Partsch C, Sippell W, MacKenzie I.Z. et al. The steroid hormonal milieu of the undisturbed human fetus and mother at 16-20 weeks gestation. J Clin Endocrinol Metab 1991; 5: 969—974.; Kay H, Bird I., Coe C.L. et al. Antenatal steroid treatment and adverse fetal effects: what is the evidence? J Soc Gynecol Investig 2000; 5: 269-278.; AlizaiN., Thomas D., LilfordRJ. et al. Feminizing genitoplasty for congenital adrenal hyperplasia: what happens at puberty? JUrol 1999; 5: 1588-1591.; Elhalaby E., Abo Sikeena M. Delayed presentation of congenital diaphragmatic hernia. Pediatr Surg Int 2002; 5-6: 480-485.; Mullis P., Hindmarsh P., Brook C.G. et al. Sodium chloride supplement at diagnosis and during infancy in children with salt-losing 21-hydroxylase deficiency. Eur J Pediatr 1990; 1: 22—25.; Charmandari E., Lichtarowicz-Krynska E., Hindmarsh PC. etal. Congenital adrenal hyperplasia: management during critical illness. Arch Dis Child 2001; 1: 26—28.; Escobar-Morreale H., Sanchon R., San Millan J.L. et al. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. J Clin Endocrinol Metab 2008; 2: 527-533.; Richards G., Grumbach M., Kaplan S.L. et al. The effect of long acting glucocorticoids on menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia. J Clin Endocrinol Metab 1978; 6: 1208—1215.; Lonning, P., Jacobs S., Jones A.L. et al. The influence of CGS 16949A on peripheral aromatisation in breast cancer patients. Br J Cancer 1991; 5: 789-793.; Speiser P., Azziz R-, Baskin L.S. et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 9: 4133-4160.; Hughes I., Read G. Menarche and subsequent ovarian function in girls with congenital adrenal hyperplasia. Horm Res 1982; 2: 100-106.; Bachelot A., Chakhtoura Z., Samara-Boustani D. et al. Bone health should be an important concern in the care of patients affected by 21 hydroxylase deficiency. Int J Pediatr Endocrinol 2010.; RosenfieldR., BickelS., Razdan A.K. et al. Amenorrhea related to progestin excess in congenital adrenal hyperplasia. Obstet Gynecol 1980; 2: 208-215.; StikkelbroeckN., HermusA., Suliman H.M. et al. Asymptomatic testicular adrenal rest tumours in dolescent and adult males with congenital adrenal hyperplasia: basal and follow-up investigation after 2.6 years. J Pediatr Endocrinol Metab 2004; 4: 645-653.; Riad-Fahmy D., Read G., Walker R.F. et al. Steroids in saliva for assessing endocrine function. Endocr Rev 1982; 4: 367—395.; Kemp Т., Safaeian M., Miner S. et al. Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin Levels. Front Oncol 2012; 2: 61.; Groschl M., Rauh M., Dorr H.G. et al. Cortisol and 17-hydroxyprogesterone kinetics in saliva after oral administration of hydrocortisone in children and young adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2002; 3: 1200-1204.; Vuorento T., Huhtaniemi I. Daily levels of salivary progesterone during menstrual cycle in adolescent girls. Fertil Steril 1992; 4: 685-690.; Gray S., Ebe L., Feldman H.A. et al. Salivary progesterone levels before menarche: a prospective study of adolescent girls. J Clin Endocrinol Metab 2010; 7: 3507-3511.; Auchus J. Management of the adult with congenital adrenal hyperplasia. Int J Pediatr Endocrinol 2010; 614107.; Klingensmith G., Garcia S., Jones H. et al. Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation, and fertility. J Pediatr 1977; 6: 996-1004.; Richards G., Grumbach M., Kaplan S.L. et al. The effect of long acting glucocorticoids on menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia. J Clin Endocrinol Metab 1978; 6: 1208-1215.; Lin-Su K., Harbison M., Lekarev O. et al. Final adult height in children with congenital adrenal hyperplasia treated with growth hormone. J Clin Endocrinol Metab 2011; 6: 1710-1717.; Korth-Schutz, S., Virdis R., Saenger P. et al. Serum androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia. J Clin Endocrinol Metab 1978; 3:452—458.; Kang M., Kim S., Lee Y.A. et al. Relationships of basal level of serum 17-hydroxyprogesterone with that of serum androstenedione and their stimulated responses to a low dose of ACTH in young adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Korean Med Sci2011; 11: 1454-1460.; Rosenfield R., Ehrlich E., Cleary R.F. et al. Adrenal and ovarian contributions to the elevated free plasma androgen levels in hirsute women. J Clin Endocrinol Metab 1972; 1: 92-98.; RosenfieldR., Fang V., Dupon С et al. The effects of low doses of depot estradiol and testosterone in teenagers with ovarian failure and Turner's syndrome. J Clin Endocrinol Metab 1973; 4: 574—580.; MaffeiL., Murata Y, Rochira V. etal. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab 2004; 1: 61—70.; Rappaport R., Cornu G., Rover P. et al. Statural growth in congenital adrenal hyperplasia treated with hydrocortisone. J Pediatr 1968; 5: 760-766.; Helleday J., Siwers В., Ritzen E.M. et al. Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency. J Clin Endocrinol Metab 1993; 4: 933—936.; Holmes-Walker D., Conway G., Honour J.W. et al. Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol 1995; 3: 291—296.; Abd El Dayem S., Anwar G., Salama H et al. Bone mineral density, bone turnover markers, lean mass, and fat mass in Egyptian children with congenital adrenal hyperplasia. Arch Med Sci 2010; 1: 104-110.; undefined

Διαθεσιμότητα: https://www.ped-perinatology.ru/jour/article/view/203

View record from BASE

12

Academic Journal